2,123
Views
8
CrossRef citations to date
0
Altmetric
Articles

Targetability of cervical cancer by magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated hyperthermia (HT) for patients receiving radiation therapy

, , , , , , , & show all
Pages 498-510 | Received 28 Oct 2020, Accepted 19 Feb 2021, Published online: 23 Mar 2021

Reference

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
  • Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri. Int J Gynecol Obstet. 2018;143:22–36.
  • Bhatla N, Berek JS, Cuello Fredes M, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet. 2019;145:129–135.
  • Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. Int J Gynecol Obstet. 2006;95:S43–S103.
  • Koh W-J, Abu-Rustum NR, Bean S, et al. Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:64–84.
  • Schwarz JK, Siegel BA, Dehdashti F, et al. Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2012;83:185–190.
  • Vistad I, Fosså SD, Dahl AAA. A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer. Gynecol Oncol. 2006;102:563–572.
  • Greimel ER, Winter R, Kapp KS, et al. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psychooncology. 2009;18:476–482.
  • Kirwan JM, Symonds P, Green JA, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol. 2003;68:217–226.
  • Elghamrawi KA, Haggag MH, Habib EE. Treatment complications among long-term survivors of cervical cancer: treated by surgery or radiotherapy. Oncol Rev. 2011;5:261–266.
  • Mallory M, Gogineni E, Jones GC, et al. Therapeutic hyperthermia: the old, the new, and the upcoming. Crit Rev Oncol Hematol. 2016;97:56–64.
  • Datta NR, Ordóñez SG, Gaipl US, et al. Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev. 2015;41:742–753.
  • Issels RD, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010;11:561–570.
  • Lutgens L, van der Zee J, Pijls-Johannesma M, et al. Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. Cochrane Database Syst Rev. 2010:CD006377.
  • Datta NR, Bose AK, Kapoor HK, et al. Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): a controlled clinical study. Indian Med Gaz. 1987;121:68–71.
  • Harima Y, Nagata K, Harima K, et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperth. 2001;17:97–105.
  • Sharma S, Singhal S, Sandhu APS, et al. Local thermo-radiotherapy in carcinoma cervix: improved local control versus increased incidence of distant metastasis . Asia Oceania J Obstet Gynaecol. 1991;17:5–12.
  • van der Zee J, González González D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 2000;355:1119–1125.
  • Vasanthan A, Mitsumori M, Park JH, et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys. 2005;61:145–153.
  • Hong-Wei C. A randomized trial of hyperthermia-radiochemotherapy for uterine cervix cancer. Clin J Clin Oncol. 1997;24:249–251.
  • Van Der Zee J, González González D. The Dutch Deep Hyperthermia trial: results in cervical cancer. Int J Hyperthermia. 2002;18:1–12.
  • Varma S, Myerson R, Moros E, et al. Simultaneous radiotherapy and superficial hyperthermia for high-risk breast carcinoma: a randomised comparison of treatment sequelae in heated versus non-heated sectors of the chest wall hyperthermia. Int J Hyperthermia. 2012;28:583–590.
  • Kapp DS, Petersen IA, Cox RS, et al. Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial. Int J Radiat Oncol Biol Phys. 1990;19:1481–1495.
  • Algan O, Fosmire H, Hynynen K, et al. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer. 2000;89:399–403.
  • Harari PM, Hynynen KH, Roemer RB, et al. Development of scanned focussed ultrasound hyperthermia: clinical response evaluation. Int J Radiat Oncol Biol Phys. 1991;21:831–840.
  • Guthkelch AN, Carter LP, Cassady JR, et al. Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial. J Neurooncol. 1991;10:271–284.
  • Marmor JB, Hahn GM. Combined radiation and hyperthermia in superficial human tumors. Cancer. 1980;46:1986–1991.
  • Corry PM, Spanos WJ, Tilchen EJ, et al. Combined ultrasound and radiation therapy treatment of human superficial tumors. Radiology. 1982;145:165–169.
  • Hurwitz MD, Kaplan ID, Hansen JL, et al. Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile. Int J Hyperthermia. 2005;21:649–656.
  • Hurwitz MD, Kaplan ID, Hansen JL, et al. Association of rectal toxicity with thermal dose parameters in treatment of locally advanced prostate cancer with radiation and hyperthermia. Int J Radiat Oncol Biol Phys. 2002;53:913–918.
  • Van Der Zee J. Heating the patient: a promising approach? Ann Oncol. 2002;13:1173–1184.
  • Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys. 1996;35:731–744.
  • Huilgol NG, Gupta S, Sridhar CR. Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Can Res Ther. 2010;6:492–496.
  • Dunlop PR, Hand JW, Dickinson RJ, et al. An assessment of local hyperthermia in clinical practice. Int J Hyperthermia. 1986;2:39–50.
  • Woeber K. Combination of ultrasound and X-ray radiation in the treatment of cancer. Int J Phys Med. 1960;4:10–19.
  • Crezee H, Van Leeuwen CM, Oei AL, et al. Thermoradiotherapy planning: integration in routine clinical practice. Int J Hyperthermia. 2016;32:41–49.
  • Fessenden P, Hand JW. Hyperthermia therapy physics. In: Smith AR, editor. Radiat Ther Physics Med Radiol (Diagnostic Imaging Radiat Oncol). Berlin: Springer-Verlag; 1995. p. 315–363.
  • Diederich CJ, Hynynen K. Ultrasound technology for hyperthermia. Ultrasound Med Biol. 1999;25:871–887.
  • Zhu L, Altman MB, Laszlo A, et al. Ultrasound hyperthermia technology for radiosensitization. Ultrasound Med Biol. 2019;45:1025–1043.
  • Zhu L, Partanen A, Talcott MR, et al. Feasibility and safety assessment of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated mild hyperthermia in pelvic targets evaluated using an in vivo porcine model. Int J Hyperthermia. 2019;36:1147–1159.
  • Chu W, Staruch RM, Pichardo S, et al. Magnetic resonance-guided high-intensity focused ultrasound hyperthermia for recurrent rectal cancer: MR thermometry evaluation and preclinical validation. Int J Radiat Oncol Biol Phys. 2016;95:1259–1267.
  • Tillander M, Hokland S, Koskela J, et al. High intensity focused ultrasound induced in vivo large volume hyperthermia under 3D MRI temperature control. Med Phys. 2016;43:1539–1549.
  • Chu W, Staruch RM, Pichardo S, et al. Safety and feasibility of MR-HIFU mild hyperthermia with radiation and chemotherapy for recurrent rectal cancer. Society for Thermal Medicine – 2018 Annual Meeting; Tucson, Arizona. 2018. p. 82.
  • Kim A. A phase I study of lyso-thermosensitive liposomal doxorubicin and MR-HIFU for pediatric refractory solid tumors. Clinicaltrials.Gov. 2015:2015–2020.
  • Bing F, Vappou J, de Mathelin M, et al. Targetability of osteoid osteomas and bone metastases by MR-guided high intensity focused ultrasound (MRgHIFU). Int J Hyperthermia. 2018;35:471–479.
  • Giles SL, Imseeh G, Rivens I, et al. MR guided high intensity focused ultrasound (MRgHIFU) for treating recurrent gynaecological tumours: a pilot feasibility study. Br J Radiol. 2019;92:20181037.
  • Tung S, Fahy AS, Lamberti-Pasculli M, et al. Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) virtual treatment planning for abdominal neuroblastoma utilizing retrospective diagnostic 3D CT images. J Pediatr Hematol Oncol. 2019;41:e443–e449.
  • Shim J, Staruch RM, Koral K, et al. Pediatric sarcomas are targetable by MR-guided high intensity focused ultrasound (MR-HIFU): anatomical distribution and radiological characteristics. Pediatr Blood Cancer. 2016;63:1753–1760.
  • Seward MC, Daniel GB, Ruth JD, et al. Feasibility of targeting canine soft tissue sarcoma with MR-guided high-intensity focused ultrasound. Int J Hyperth. 2018;35:205–215.
  • Beserra A, Pichardo S, Kisselgoff D, et al. Targeting feasibility evaluation of magnetic resonance-guided focused ultrasound in the management of osteomyelitis: a virtual treatment planning study in 75 patients. Int J Hyperth. 2019;36:1012–1023.
  • Machtinger R, Inbar Y, Ben-Baruch G, et al. MRgFUS for pain relief as palliative treatment in recurrent cervical carcinoma: a case report. Gynecol Oncol. 2008;108:241–243.
  • Abel M, Ahmed H, Leen E, et al. Ultrasound-guided trans-rectal high-intensity focused ultrasound (HIFU) for advanced cervical cancer ablation is feasible: a case report. J Ther Ultrasound. 2015;3:3–6.
  • Kim BS, Kim IJ, Kim SJ, et al. The prognostic value of the metabolic tumor volume in FIGO stage IA to IIB cervical cancer for tumor recurrence: Measured by F-18 FDG PET/CT. Nucl Med Mol Imaging. 2011;45:36–42.
  • Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with cervical cancer. Int J Radiat Oncol. 2001;51:222.
  • Chung HH, Kim JW, Han KH, et al. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer. Gynecol Oncol. 2011;120:270–274.
  • Maldonado PA, Stuparich MA, McIntire DD, et al. Proximity of uterosacral ligament suspension sutures and S3 sacral nerve to pelvic landmarks. Int Urogynecol J. 2017;28:77–84.
  • Huisman M, Lam MK, Bartels LW, et al. Feasibility of volumetric MRI-guided high intensity focused ultrasound (MR-HIFU) for painful bone metastases. J Ther Ultrasound. 2014;2:16.
  • Hurwitz MD, Ghanouni P, Kanaev SV, et al. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. J Natl Cancer Inst. 2014;106:1–9.
  • Ju SG, Huh SJ, Shin JS, et al. Different effects of bladder distention on point A-based and 3D-conformal intracavitary brachytherapy planning for cervical cancer. J Radiat Res. 2013;54:349–356.
  • Verpalen IM, van 't Veer-Ten Kate M, de Boer E, et al. Development and clinical evaluation of a 3-step modified manipulation protocol for MRI-guided high-intensity focused ultrasound of uterine fibroids. Eur Radiol. 2020;30:3869–3878.
  • Park MJ, Kim YS, Rhim H, et al. Technique to displace bowel loops in MRI-guided high-intensity focused ultrasound ablation of fibroids in the anteverted or anteflexed uterus. Am J Roentgenol. 2013;201:761–765.
  • Kim YS, Lim HK, Rhim H. Magnetic resonance imaging-guided high- intensity focused ultrasound ablation of uterine fibroids: effect of bowel interposition on procedure feasibility and a unique bowel displacement technique. PLoS One. 2016;11:e0155670.
  • Duc NM, Keserci B. Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids. Diagn Interv Radiol. 2018;24:283–291.
  • Stewart AJ, Cormack RA, Lee H, et al. Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy. Int J Radiat Oncol Biol Phys. 2008;72:843–848.
  • Kim RY, Shen S, Lin HY, et al. Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2010;76:485–489.
  • Kim Y. Sun Clinical application of high-intensity focused ultrasound ablation for uterine fibroids. Biomed Eng Lett. 2017;7:99–105.
  • Nyapathy V, Polina L. MRgFUS treatment of uterine fibroid in a nulliparous woman with acute retention of urine. J Radiol Case Rep. 2012;6:1–8.
  • Hesley GK, Felmlee JP, Gebhart JB, et al. Noninvasive treatment of uterine fibroids: early mayo clinic experience with magnetic resonance imaging-guided focused ultrasound. Mayo Clin Proc. 2006;81:936–942.
  • Harrell FE. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. 2nd ed. New York, NY: Springer; 2017.
  • Oh J, Seol KH, Choi YS, et al. Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapy. Yeungnam Univ J Med. 2019;36:115–123.
  • Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535–540.
  • Suprasert P, Srisomboon J, Charoenkwan K, et al. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer. J Obstet Gynaecol. 2010;30:294–298.
  • Dharmaiah S, Zeng J, Rao VS, et al. Clinical and dosimetric evaluation of recurrent breast cancer patients treated with hyperthermia and radiation. Int J Hyperth. 2019;36:986–992.
  • Ho YJ, Li JP, Fan CH, et al. Ultrasound in tumor immunotherapy: current status and future developments. J Control Release. 2020;323:12–23.
  • Corry PM, Barlogie B, Tilchen EJ, et al. Ultrasound-induced hyperthermia for the treatment of human superficial tumors. Int J Radiat Oncol Biol Phys. 1982;8:1225–1229.
  • Bornstein BA, Zouranjian PS, Hansen JL, et al. Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma. Int J Radiat Oncol Biol Phys. 1993;25:79–85.
  • Diederich CJ, Wootton J, Prakash P, et al. Catheter-based ultrasound hyperthermia with HDR brachytherapy for treatment of locally advanced cancer of the prostate and cervix. Proc SPIE Int Soc Opt Eng. 2011;7901:79010O.
  • Hurwitz MD, Hansen JL, Prokopios-Davos S, et al. Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153. Cancer. 2011;117:510–516.
  • Fosmire H, Hynynen K, Drach GW, et al. Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1993;26:253–259.
  • Myerson RJ, Straube WL, Moros EG, et al. Simultaneous superficial hyperthermia and external radiotherapy: report of thermal dosimetry and tolerance to treatment. Int J Hyperth. 1999;15:251–266.
  • Xia T, Sun Q, Shi X, et al. Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy. Int J Clin Oncol. 2001;6:138–142.
  • Emami B, Myerson RJ, Cardenes H, et al. Combined hyperthermia and irradiation in the treatment of superficial tumors: results of a prospective randomized trial of hyperthermia fractionation (1/wk vs 2/wk). Int J Radiat Oncol Biol Phys. 1992;24:145–152.
  • Kapp DS, Cox RS, Fessenden P, et al. Parameters predictive for complications of treatment with combined hyperthermia and radiation therapy. Int J Radiat Oncol Biol Phys. 1992;22:999–1008.
  • Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005;23:3079–3085.
  • Chu W, Staruch R, Pichardo S, et al. MR-HIFU mild hyperthermia for locally recurrent rectal cancer: temperature mapping and heating quality in first patient. 12th International Congress of Hyperthermic Oncology; New Orleans, LA; 2016. p. 144.
  • Zhu L, Lam D, Pacia CP, et al. Characterization of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-induced large-volume hyperthermia in deep and superficial targets in a porcine model. Int J Hyperthermia. 2020;37:1159–1173.